Akebia Therapeutics (AKBA) Non-Current Assets: 2016-2025
Historic Non-Current Assets for Akebia Therapeutics (AKBA) over the last 10 years, with Sep 2025 value amounting to $105.8 million.
- Akebia Therapeutics' Non-Current Assets fell 1.13% to $105.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $105.8 million, marking a year-over-year decrease of 1.13%. This contributed to the annual value of $106.8 million for FY2024, which is 13.53% down from last year.
- Akebia Therapeutics' Non-Current Assets amounted to $105.8 million in Q3 2025, which was down 4.62% from $110.9 million recorded in Q2 2025.
- In the past 5 years, Akebia Therapeutics' Non-Current Assets ranged from a high of $280.8 million in Q2 2021 and a low of $105.8 million during Q3 2025.
- Its 3-year average for Non-Current Assets is $118.4 million, with a median of $110.9 million in 2025.
- Per our database at Business Quant, Akebia Therapeutics' Non-Current Assets tumbled by 41.00% in 2021 and then rose by 2.63% in 2025.
- Quarterly analysis of 5 years shows Akebia Therapeutics' Non-Current Assets stood at $258.2 million in 2021, then plummeted by 33.82% to $170.9 million in 2022, then fell by 27.69% to $123.6 million in 2023, then dropped by 13.53% to $106.8 million in 2024, then fell by 1.13% to $105.8 million in 2025.
- Its last three reported values are $105.8 million in Q3 2025, $110.9 million for Q2 2025, and $106.4 million during Q1 2025.